Badowska-Kozakiewicz AM (2012) Biological role of prolactin. Menopause Rev 4: 305-308.

Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice. Endocr Rev 19: 225-268.

Carpini JD, Karam AK, Montgomery L (2010) Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 13: 43-58.

Clapp C, Thebault S, Martínez de la Escalera G (2008) Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland. J Mammary Gland Biol Neoplasia 13: 55-67.

Dorn CR, Taylor DO, Schneider R, Hibbard HH, Klauber MR (1968) Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40: 307-318

Estrela-Lima A, Araújo MS, Costa-Neto JM, Teixeira-Carvalho A, Barrouin-Melo SM, Cardoso SV, Martins-Filho OA, Serakides R, Cassali GD (2010) Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer 10: 256.

Fernandez I, Touraine P, Goffin V (2010) Prolactin and Human Tumourogenesis. J Neuroendocrinol 22: 771-777.

Ferreira M, Mesquita M, Quaresma M, André S (2008) Prolactin receptor expression in gynaecomastia and male breast carcinoma. Histopathology 53: 56-61.

Gill S, Peston D, Vonderhaar BK, Shousha S (2001) Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol 54: 956-960.

Giménez F, Hecht S, Craig LE, Legendre AM (2010) Early detection, aggressive therapy: optimizing the management of feline mammary masses. J Feline Med Surg 123: 214-224

Ginsburg E, Vonderhaar BK (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55: 2591-2595.

Giziński S, Boryczko Z, Katkiewicz M, Bostedt H (2004) Investigations on the peripheral steroid hormone concentration and on the estrogen receptor density and antigen Ki-67 distribution in mammary gland tumors of different classifications in bitches. Tierarztl Prax 32: 214-220.

Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674.

Harvey S, Martínez-Moreno CG, Luna M, Arámburo C (2015) Autocrine/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview. Gen Comp Endocrinol 220: 103-111.

Islam MS, Matsumoto M, Hidaka R, Miyoshi N, Yasuda N (2012) Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis. Vet J 192: 338-344.

Jensen HM, Chen I, DeVault MR, Lewis AE (1982) Angiogenesis Induced by “Normal” Human Breast Tissue: A Probable Marker for Precancer. Science 218: 293-295.

Karten HJ (1998) Information Management of Confocal Microscopy Images: Traditional Text-Based Databases and Image Gallery Databases. In: Confocal Microscopy Methods and Protocols. Humana Press, New Jersey, pp 403-420

Kim JH, Chon S-K, Im KS, Kim NH, Sur JH (2013) Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study. Can J Vet Res 77: 142-149

Klopfleisch R, von Euler H, Sarli G, Pinho SS, Gärtner F, Gruber AD (2011) Molecular Carcinogenesis of Canine Mammary Tumors: news from an old disease. Vet Pathol 48(1): 98-116.

Köllermann J, Helpap B (2001) Expression of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Flk-1 in Benign, Premalignant, and Malignant Prostate Tissue. Am J Clin Pathol 116: 115-121.

Lana SE, Rutterman GR, Wthrow SJ (2007) Tumors of the mammary gland. In: Withrow SJ, Vail DM (eds) Withrow & MacEwen’s small animal clinical oncology. Saunders Elsevier, St. Louis, pp 619-636

Leav I, Merk FB, Lee KF, Loda M, Mandoki M, McNeal JE, Ho SM (1999) Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions. Am J Pathol 154: 863-870.

Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE (2009) Biological Significance of Prolactin in Gynecologic Cancers. Cancer Res 69: 5226-5233.

Li Y, Clevenger CV, Minkovsky N, Kumar KGS, Raghunath PN, Tomaszewski JE, Spiegelman VS, Fuchs SY (2006) Stabilization of prolactin receptor in breast cancer cells. Oncogene 25: 1896-1902.

Marano RJ, Ben-Jonathan N (2014) Minireview: Extrapituitary Prolactin: An Update on the Distribution, Regulation, and Functions. Mol Endocrinol 28: 622-633.

Meuten DJ (2017) Tumors in Domestic Animals. 5th ed., Wiley, Hoboken.

Michel E, Feldmann SK, Kowalewski MP, Bley CR, Boos A, Guscetti F, Reichler IM (2012) Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas. BMC Vet Res 8: 72.

Michel E, Rohrer Bley C, Kowalewski MP, Feldmann SK, Reichler IM (2014) Prolactin – to be reconsidered in canine mammary tumourigenesis? Vet Comp Oncol 12: 93-105.

Millanta F, Lazzeri G, Vannozzi I, Viacava P, Poli A (2002) Correlation of Vascular Endothelial Growth Factor Expression to Overall Survival in Feline Invasive Mammary Carcinomas. Vet Pathol 39: 690-696

Mills SW, Musil KM, Davies JL, Hendrick S, Duncan C, Jackson ML, Kidney B, Philibert H, Wobeser BK, Simko E (2015) Prognostic Value of Histologic Grading for Feline Mammary Carcinoma: a retrospective survival analysis. Vet Pathol 52: 238-249

Misdorp W, Romijin A, Hart A (1991) Feline mammary tumors: a case-control study of hormonal factors. Anticancer Res 11: 1793-1797

Nieto A, Peña L, Pérez-Alenza MD, Sánchez MA, Flores JM, Castaño M (2000) Immunohistologic Detection of Estrogen Receptor Alpha in Canine Mammary Tumors: Clinical and Pathologic Associations and Prognostic Significance. Vet Pathol 37: 239-247

Overley B, Shofer FS, Goldschmidt MH (2005) Association between Ovarihysterectomy and Feline Mammary Carcinoma. J Vet Intern Med 19: 560-563.

Peirce S, Chen WY (2001) Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 171: R1-R4.

Philips N, McFadden K (2004) Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells. Cancer Lett 206: 63-68.

Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY (2009) Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells. Cancer Res 69: 3165-3172.

Queiroga FL, Pérez‐Alenza MD, González Gil A, Silvan G, Peña L, Illera JC (2014) Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours. Vet Rec 175: 403-403.

Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV (1997) Expression of Prolactin and Its Receptor in Human Breast Carcinoma. Endocrinology 138: 5555-5560.

Rutteman GR, Bevers MM, Misdorp W, Van den Brom WE (1989) Anterior pituitary function in female dogs with mammary tumors: II. Prolactin. Anticancer Res 9: 241-245

Skałba W, Lemm M, Witek A (2016) The role of pituitary and extrapituitary prolactin in reproduction and oncology. Ann Acad Med Siles 70: 46-50.

Sorenmo K (2003) Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 33: 573-596.

Spoerri M, Guscetti F, Hartnack S, Boos A, Oei C, Balogh O, Nowaczyk RM, Michel E, Reichler IM, Kowalewski MP (2015) Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors. BMC Vet Res 11: 235.

Strum JM (1983) Angiogenic responses elicited from chorioallantoic membrane vessels by neoplastic, preneoplastic, and normal mammary tissues from GR mice. Am J Pathol 111: 282-287

van Garderen E, van der Poel HJ, Swennenhuis JF, Wissink EH, Rutteman GR, Hellmén E, Mol JA, Schalken JA (1999) Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors. Endocrinology 140: 5907-5914.

Viste JR, Myers SL, Singh B, Simko E (2002) Feline mammary adenocarcinoma: tumor size as a prognostic indicator. Can Vet J 43: 33-37

Zappulli V, Rasotto R, Caliari D, Mainenti M, Peña L, Goldschmidt MH, Kiupel M (2015) Prognostic Evaluation of Feline Mammary Carcinomas: a review of the literature. Vet Pathol 52: 46-60.